Profile for European Patent Office Patent: 1304992
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Netherlands | C300617 | ⤷ Start Trial |
| Lithuania | PA2013025 | ⤷ Start Trial |
| Sweden | 1390049-3 | ⤷ Start Trial |
| Luxembourg | 92401 | ⤷ Start Trial |
| Denmark | CR 2013 00053 | ⤷ Start Trial |
| Lithuania | PA2013025,C1304992 | ⤷ Start Trial |
| Ireland | 2013/044 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1304992
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
